The Van Meir research team strives to understand the molecular basis for human tumor development and develop new therapeutic agents with the ultimate goal of improving cancer patient treatment.
To help cancer patients, decoding the molecular puzzle of how tumors develop is imperative. Cells form tumors when oncogenes are activated and tumor suppressors are inactivated, and Dr. Van Meir’s team is seeking ways to block oncogenes and reactivate silenced tumor suppressors to block tumor gro...
Dr. Leavenworth joined UAB Neurosurgery as an Assistant Professor on Oct. 1, 2016. Previously, Dr. Leavenworth was at the Dana-Farber Cancer Institute at Harvard University. Dr. Leavenworth completed medical school at Nantong University (NTU) School of Medicine, Nantong, Jiangsu, China. She then finished her PhD training in molecular biology, microbiology and biochemistry with a focus on immunology at Southern Illinois University School of Medicine. She was at Harvard Medical School since 2009 ...
After graduating from medical school at the University of Tsukuba in Japan, Dr Osuka completed a residency program in Neurosurgery. While he was involved in the treatment of many types of diseases during his residency training, he developed a great interest in malignant brain tumors. Caring for patients with malignant brain tumors gave him first-hand experience with the difficulties of disease control and severe outcome for the patients. These experiences prompted his interest in training in bas...
